|
1
|
Harris HR and Terry KL: Polycystic ovary
syndrome and risk of endometrial, ovarian, and breast cancer: A
systematic review. Fertil Res Pract. 2:142016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Okamura Y, Saito F, Takaishi K, Motohara
T, Honda R, Ohba T and Katabuchi H: Polycystic ovary syndrome:
Early diagnosis and intervention are necessary for fertility
preservation in young women with endometrial cancer under 35 years
of age. Repro Med Biol. 16:67–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rotterdam ESHRE/ASRM-Sponsored PCOS
Consensus Workshop Group, : Revised 2003 consensus on diagnostic
criteria and long-term health risks related to polycystic ovary
syndrome. Fertil Steril. 81:19–25. 2004. View Article : Google Scholar
|
|
4
|
Raglan O, Kalliala I, Markozannes G,
Cividini S, Gunter MJ, Nautiyal J, Gabra H, Paraskevaidis E,
Martin-Hirsch P, Tsilidis KK and Kyrgiou M: Risk factors for
endometrial cancer: An umbrella review of the literature. Int J
Cancer. 145:1719–1730. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang S, Gong TT, Liu FH, Jiang YT, Sun H,
Ma XX, Zhao YH and Wu QJ: Global, regional and national burden of
endometrial cancer, 1990–2017: Results from the gobal burden of
disease study, 2017. Front Oncol. 19:14402019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Balen A: Polycystic ovary syndrome and
cancer. Hum Reprod Update. 7:522–525. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haoula Z, Salman M and Atiomo W:
Evaluating the association between endometrial cancer and
polycystic ovary syndrome. Hum Reprod. 27:1327–1331. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang HP, Wentzensen N, Trabert B, Gierach
GL, Felix AS, Gunter MJ, Hollenbeck A, Park Y, Sherman ME and
Brinton LA: Endometrial cancer risk factors by 2 main histologic
subtypes. Am J Epidemiol. 177:142–151. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feinberg J, Albright B, Black J, Lu L,
Passarelli R, Gysler S, Whicker M, Altwerger G, Menderes G, Hui P,
et al: Ten-year comparison study of type 1 and 2 endometrial
cancers: Risk factors and outcomes. Gynecol Obs Invest. 84:290–297.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Navaratnarajah R, Pillay OC and Hardiman
P: Polycystic ovary syndrome and endometrial cancer. Semin Reprod
Med. 26:62–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park JC, Lim SY, Jang TK, Bae JG, Kim JI
and Rhee JH: Endometrial histology and predictable clinical factors
for endometrial disease in women with polycystic ovary syndrome.
Clin Exp Reprod Med. 38:42–46. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hardiman P, Pillay OS and Atiomo W:
Polycystic ovary syndrome and endometrial carcinoma. Lancet.
361:1810–1812. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gadducci A, Gargini A, Palla E, Fanucchi A
and Genazzani AR: Polycystic ovary syndrome and gynaecological
cancers: Is there a link? Gynecol Endo. 20:200–208. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fanta M: Is polycystic ovary syndrome, a
state of relative oestrogen excess, a real risk factor for
oestrogen-dependant malignancies? Gynecol Endocrinol. 29:145–147.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pillay OC, Fong LFW, Crow JC, Benjamin E,
Mould T, Atiomo W, Menon PA, Leonard AJ and Hardiman P: The
association between polycystic ovaries and endometrial cancer. Hum
Reprod. 21:924–929. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Atiomo W, Khalid S, Parameshweran S, Houda
M and Layfield R: Proteomic biomarkers for the diagnosis and risk
stratification of polycystic ovary syndrome: A systemic review.
BJOG. 116:137–143. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chittenden BG, Fullerton G, Maheshwari A
and Bhattacharya S: Polycystic ovary syndrome and the risk of
gynaecological cancer: A systematic review. Reprod Biomed Online.
19:398–405. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barry JA, Azizia MM and Hardiman PJ: Risk
of endometrial, ovarian and breast cancer in women with polycystic
ovary syndrome: A systematic review and meta-analysis. Hum Reprod
Update. 20:748–758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Holm NSL, Glintborg D, Andersen MS,
Schledermann D and Ravn P: The prevalence of endometrial
hyperplasia and endometrial cancer in women with polycystic ovary
syndrome or hyperandrogenism. Acta Obstet Gynecol Scand.
91:1173–1176. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ho SP, Tan KT, Pang MW and Ho TH:
Endometrial hyperplasia and the risk of endometrial carcinoma.
Singapore Med J. 38:11–15. 1997.PubMed/NCBI
|
|
21
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron
I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: The Prisma 2020 statement: An updated guideline for
reporting systematic reviews. Syst Rev. 10:892021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stroup DF, Berlin JA, Morton SC, Olkin I,
Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA and Thacker
SB: Meta-analysis of observational studies in epidemiology: A
proposal for reporting. Meta-analysis Of observational studies in
epidemiology (MOOSE) group. JAMA. 283:2008–2012. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cumpston M, Li T, Page MJ, Chandler J,
Welch VA, Higgins JP and Thomas J: Updated guidance for trusted
systematic reviews: A new edition of the cochrane handbook for
systematic reviews of interventions. Cochrane Database Syst Rev.
10:ED0001422019.PubMed/NCBI
|
|
24
|
Review Manager (RevMan) [Computer
program]. Version 5.4. The Cochrane Collaboration; 2020
|
|
25
|
Wells GA, Wells G, Shea B, Shea B,
O'Connell D, Peterson J, Welch, Losos M, Tugwell P, Ga SW, et al:
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of
Nonrandomised Studies in Meta-Analyses.
|
|
26
|
Smittenaar C, Petersen K, Stewart K and
Moitt N: Cancer incidence and mortality projections in the UK until
2035. Br J Cancer. 25:1147–1155. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kilicdag EB, Haydardedeoglu B, Cok T,
Parlakgumus AH, Simsek E and Bolat FA: Polycystic ovary syndrome
and increased polyp numbers as risk factors for malignant
transformation of endometrial polyps in premenopausal women. Int J
Gynecol Obstet. 112:200–203. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ding DC, Chen W, Wang JH and Lin SZ:
Association between polycystic ovarian syndrome and endometrial,
ovarian, and breast cancer: A population-based cohort study in
Taiwan. Medicine (Baltimore). 97:e126082018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shen CC, Yang AC, Hung JH, Hu LY and Tsai
SJ: A nationwide population-based retrospective cohort study of the
risk of uterine, ovarian and breast cancer in women with polycystic
ovary syndrome. Oncologist. 20:45–49. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Niwa K, Imai A, Hashimoto M, Yokoyama Y,
Mori H, Matsuda Y and Tamaya T: A case-control study of uterine
endometrial cancer of pre- and post-menopausal women. Oncol Rep.
7:89–93. 2000.PubMed/NCBI
|
|
31
|
Escobedo LG, Lee NC, Peterson HB and Wingo
PA: Infertility-associated endometrial cancer risk may be limited
to specific subgroups of infertile women. Obstet Gynecol.
77:124–128. 1991.PubMed/NCBI
|
|
32
|
Wild S, Pierpoint T, Jacobs H and McKeigue
P: Long-term consequences of polycystic ovary syndrome: Results of
a 31 year follow-up study. Hum Fertil (Camb). 3:101–105. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Iatrakis G, Tsionis C, Adonakis G,
Stoikidou M, Anthouli-Anagnostopoulou F, Parava M, Vouxinou A,
Georgopoulos NA and Kourounis G: Polycystic ovarian syndrome,
insulin resistance and thickness of the endometrium. Eur J Obstet
Gynecol Reprod Biol. 127:218–221. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zucchetto A, Serraino D, Polesel J, Negri
E, De Paoli A, Dal Maso L, Montella M, La Vecchia C, Franceschi S
and Talamini R: Hormone-related factors and gynecological
conditions in relation to endometrial cancer risk. Eur J Cancer
Prev. 18:316–321. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fearnley EJ, Marquart L, Spurdle AB,
Weinstein P and Webb PM: Polycystic ovary syndrome increases the
risk of endometrial cancer in women aged less than 50 years: An
Australian case-control study. Cancer Causes Control. 21:2303–2308.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gottschau M, Kjaer SK, Jensen A, Munk C
and Mellemkjaer L: Risk of cancer among women with polycystic ovary
syndrome: A Danish cohort study. Gynecol Oncol. 136:99–103. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Prakansamut N, Sirayapiwat P and
Triratanachat S: The percentages of endometrial hyperplasia and
endometrial cancer among polycystic ovary syndrome (PCOS) patients
presenting with abnormal menstrual pattern. J Med Assoc Thai.
97:159–164. 2014.PubMed/NCBI
|
|
38
|
Indhavivadhana S, Rattanachaiyanont M,
Wongwananuruk T, Techatraisak K, Rayasawath N and Dangrat C:
Endometrial neoplasia in reproductive-aged Thai women with
polycystic ovary syndrome. Int J Gynaecol Obstet. 142:170–175.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Goldzieher JW: Polycystic ovarian disease.
Fertil Steril. 35:371–394. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
CDC, . Health Statistics 2011. https://ftp.cdc.gov/pub/Health_Statistics/NCHS/Publications/ICD9-CM/2011/December
3–2022
|
